A phase 1/2 study of intermittent, high dose sunitinib in patients with advanced solid tumors.

被引：1
|
作者：
Rovithi, Maria
Labots, Marlette
Richard
Honeywell
Ten Tije, Albert J.
Ruijter, Rita
Skardhamar, Mikkjal
Peters, Godefridus J.
Voortman, Jens
Verheul, Henk M. W.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.2591
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2591
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Effect of food on the pharmacokinetics of high dose intermittent sunitinib in patients with advanced solid tumors
    Gerritse, Sophie L.
    Labots, Mariette
    Rovithi, Maria
    Colbers, Angela
    Loosveld, Olaf J. L.
    Skardhamar, Mikkjal
    van Erp, Nielka P.
    Verheul, Henk M. W.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [2] Phase IB dose escalation study of bortezomib and sunitinib in patients with refractory solid tumors.
    Kauh, J. S.
    Harvey, R. D.
    Lawson, D. H.
    Owonikoko, T. K.
    Tighiouart, M.
    Ramalingam, S. S.
    Shin, D. M.
    Lewis, C. M.
    El-Rayes, B. F.
    Khuri, F. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Phase Ib Study of High-dose Intermittent Afatinib in Patients With Advanced Solid Tumors
    Camidge, D. Ross
    Sequist, Lecia, V
    Janne, Pasi A.
    Weickhardt, Andrew J.
    Dowling, Elizabeth S.
    Alicea, Jeanette
    Fan, Jean
    Oxnard, Geoffrey R.
    CLINICAL LUNG CANCER, 2018, 19 (05) : E655 - E665
  • [4] A phase 1 study of oral navelbine in patients with advanced solid tumors.
    Rajdev, L
    Dai, Q
    Mani, S
    Goldberg, G
    Baker, C
    Hoschander, S
    Sparano, J
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6137S - 6137S
  • [5] A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumors.
    Berlin, Jordan
    Ramanathan, Ramesh K.
    Strickler, John H.
    Subramaniam, Deeps Suresh
    Hurwitz, Herbert
    Kang, Yoon-Koo
    Kim, Tae-You
    Shepherd, Stacie Peacock
    Xiong, Hao
    Hetman, Robert
    Nickner, Caroline
    Dudley, Matthew W.
    Giranda, Vincent L.
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] A phase I dose escalation study of sunitinib plus capecitabine in patients with advanced solid tumors
    Sweeney, C.
    Verschraegen, C.
    Chiorean, G.
    Lee, F.
    Jones, S.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H., III
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Robert, Francisco
    Sandler, Alan
    Schiller, Joan H.
    Liu, Glenn
    Harper, Karen
    Verkh, Lev
    Huang, Xin
    Ilagan, Jennifer
    Tye, Lesley
    Chao, Richard
    Traynor, Anne M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 669 - 680
  • [8] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Francisco Robert
    Alan Sandler
    Joan H. Schiller
    Glenn Liu
    Karen Harper
    Lev Verkh
    Xin Huang
    Jennifer Ilagan
    Lesley Tye
    Richard Chao
    Anne M. Traynor
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 669 - 680
  • [9] Individual PK-guided sunitinib dosing: A feasibility study in patients with advanced solid tumors.
    Lankheet, Nienke A. G.
    Kloth, Jacqueline S. L.
    Gadellaa-van Hooijdonk, Christa G. M.
    Cirkel, Geert A.
    Mathijssen, Ron H. J.
    Lolkema, Martijn P. J. K.
    Schellens, Jan H. M.
    Voest, Emile E.
    Sleijfer, Stefan
    Beijnen, Jos H.
    Huitema, Alwin D. R.
    Steeghs, Neeltje
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] A phase I QTc study of tivozanib in patients with advanced solid tumors.
    Chadha, Manpreet Kaur
    Infante, Jeffrey R.
    Cotreau, Monette M.
    Jacobson, Lindsey
    Strahs, Andrew Louis
    Slichenmyer, William
    Vargo, Dennis
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
12345